Nigel Raymond Stevenson
Chief Tech/Sci/R&D Officer at VIVOS INC.
Profile
Nigel Raymond Stevenson is the founder of TcNet LLC.
He currently holds the position of Chief Science Officer at Vivos, Inc. and Chief Operating Officer at Exubrion Therapeutics, Inc. He previously worked as Vice President-Production & Research at Theragenics Corp., Chief Operating Officer at Clear Vascular, Inc., Chief Operating Officer at Trace Life Sciences, Inc., and Head-Isotope Production & Research at Tri University Mezzon Facility.
Dr. Stevenson earned a doctorate degree from the University of London in 1983.
Nigel Raymond Stevenson active positions
Companies | Position | Start |
---|---|---|
VIVOS INC. | Chief Tech/Sci/R&D Officer | - |
TcNet LLC | Chief Executive Officer | - |
Exubrion Therapeutics , Inc.
Exubrion Therapeutics , Inc. Medical SpecialtiesHealth Technology Exubrion Therapeutics, Inc. develops electron therapeutic veterinary devices. The company is based in Buford, GA. The company was founded by Dennis F. Steadman. The CEO is Peter Selover. | Chief Operating Officer | 2018-12-31 |
Former positions of Nigel Raymond Stevenson
Companies | Position | End |
---|---|---|
Tri University Mezzon Facility
Tri University Mezzon Facility Miscellaneous Commercial ServicesCommercial Services Tri University Mezzon Facility provides subatomic physics laboratories. The firm’s technical services include beamlines, information systems & technology, science-technology, diagnostics group, engineering, operations, ATG and radiation protection. The company was founded in 1968 and is headquartered in Vancouver, CA. | Corporate Officer/Principal | - |
Trace Life Sciences, Inc.
Trace Life Sciences, Inc. Chemicals: SpecialtyProcess Industries Trace Life Sciences, Inc. manufactures radiochemical, radiopharmaceuticals and research isotopes for medical imaging and therapy. The firm produces radiopharmaceutical and radiochemical isotopes used in nuclear medicine to diagnose ischemia, mycocardial infarction, and molecular imaging. The compnay is headquartered in Denton, TX. | Chief Operating Officer | - |
Theragenics Corp.
Theragenics Corp. Medical SpecialtiesHealth Technology Theragenics Corp. develops, manufactures and markets medical devices. It offers wound closure, vascular access, and specialty needle products. The company was founded in 1981 and is headquartered in Buford, GA. | Corporate Officer/Principal | - |
Clear Vascular, Inc.
Clear Vascular, Inc. Pharmaceuticals: MajorHealth Technology Clear Vascular, Inc. develops radionuclide products for multiple clinical applications. The firm has developed an injectable, targeted radiopharmaceutical agent, Tin-Annexin, for imaging and therapy of inflammatory tissues, initially targeting vulnerable and unstable plaque. It is a private radiopharmaceutical company developing a unique radionuclide for multiple clinical applications including diagnosis and therapy. The company was founded by Gilbert R. Gonzales in 2005 and is headquartered in Austin, TX. | Chief Operating Officer | - |
Training of Nigel Raymond Stevenson
University of London | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
VIVOS INC. | Health Technology |
Private companies | 6 |
---|---|
Theragenics Corp.
Theragenics Corp. Medical SpecialtiesHealth Technology Theragenics Corp. develops, manufactures and markets medical devices. It offers wound closure, vascular access, and specialty needle products. The company was founded in 1981 and is headquartered in Buford, GA. | Health Technology |
Clear Vascular, Inc.
Clear Vascular, Inc. Pharmaceuticals: MajorHealth Technology Clear Vascular, Inc. develops radionuclide products for multiple clinical applications. The firm has developed an injectable, targeted radiopharmaceutical agent, Tin-Annexin, for imaging and therapy of inflammatory tissues, initially targeting vulnerable and unstable plaque. It is a private radiopharmaceutical company developing a unique radionuclide for multiple clinical applications including diagnosis and therapy. The company was founded by Gilbert R. Gonzales in 2005 and is headquartered in Austin, TX. | Health Technology |
Trace Life Sciences, Inc.
Trace Life Sciences, Inc. Chemicals: SpecialtyProcess Industries Trace Life Sciences, Inc. manufactures radiochemical, radiopharmaceuticals and research isotopes for medical imaging and therapy. The firm produces radiopharmaceutical and radiochemical isotopes used in nuclear medicine to diagnose ischemia, mycocardial infarction, and molecular imaging. The compnay is headquartered in Denton, TX. | Process Industries |
Tri University Mezzon Facility
Tri University Mezzon Facility Miscellaneous Commercial ServicesCommercial Services Tri University Mezzon Facility provides subatomic physics laboratories. The firm’s technical services include beamlines, information systems & technology, science-technology, diagnostics group, engineering, operations, ATG and radiation protection. The company was founded in 1968 and is headquartered in Vancouver, CA. | Commercial Services |
TcNet LLC | |
Exubrion Therapeutics , Inc.
Exubrion Therapeutics , Inc. Medical SpecialtiesHealth Technology Exubrion Therapeutics, Inc. develops electron therapeutic veterinary devices. The company is based in Buford, GA. The company was founded by Dennis F. Steadman. The CEO is Peter Selover. | Health Technology |
- Stock Market
- Insiders
- Nigel Raymond Stevenson